Nexstim Plc to present depression led strategy at Investor Conference Sijoittaja 2018 in Helsinki

- 19/09/2018

Helsinki, Finland: 19 September 2018 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depressive Disorder (MDD), announces that the company will present its new corporate strategy and meet with investors at Sijoittaja 2018 in Helsinki, tomorrow Thursday September 20th.

Mikko Karvinen, Chief Financial Officer, will present on the company and its NBT® System for the treatment of MDD at 12:55 at Messukeskus Helsinki, Expo and Convention Centre.

More info on Nexstim’s website.